JAVELIN BIOTECH INC
Woburn, MA · Medtech · Private
Human liver tissue chip integrated with translational software to predict drug hepatic clearance and metabolism
javelinbio.com →- Grants
- $3.9M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 27
- 4 granted · 23 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · DDI-on-a-chip: an optimized liver microphysiological system and microenvironment for complex drug-drug interaction studies | $259,613 | |
| Federal grant | Department of Health and Human Services · Phase I · Multi-Tissue MAFLD Chip for Mechanism-Based Drug Testing | $314,803 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Hepatic Clearance Chip for Pharmacokinetics | $1,009,594 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Hepatic Clearance Chip for Pharmacokinetics | $1,009,594 | |
| Federal grant | Department of Health and Human Services · Phase II · Hepatic Clearance Chip for Pharmacokinetics | $974,458 | |
| Federal grant | Department of Health and Human Services · Phase I · Investigating the Impact of Metabolic Disease States on the Pharmacodynamics and Toxicity of FDA-Approved Antisense Oligonucleotides Using an Integrated Liver-Kidney Model | $349,677 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2002 | Autonomix Medical, Inc. | — | $8.9M |
| 2003 | Newmark Diagnostics LLC | — | — |
| 2004 | OVITZ CORPORATION | — | — |
| 2005 | JAVELIN BIOTECH INC | — | — |
| 2006 | SANAHEAL, INC. | — | — |
| 2007 | NANONERVE, INC. | — | — |
| 2008 | PolyK Technologies, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Microfluidic Systems And Support Modulegranted
- Microphysiological Platform For Drug Absorption Modelingapplication
- Microfluidic Devices And Methods Of Designing And Using Microfluidic Devicesgranted
- Performing Pharmacodynamics Evaluations Using Microfluidic Devicesgranted
- Micro-physiological Platform For Immune Response Modelingapplication
- Microfluidic Platform For Detection Of Liver Injuryapplication
- Tapping Device for Microfluidic Systemapplication
- Neurodegenerative Target Discovery Platformapplication
- Neurodegenerative Target Discovery Platformgranted
- Microfluidic Platform For Target And Biomarker Discovery For Non-alcoholic Fatty Liver Diseaseapplication
- Performing Pharmacodynamics Evaluations Using Microfluidic Devicesapplication
- Microfluidic Systems And Support Moduleapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.